Tuesday, February 9, 2010 Previous editions
Friday, November 27, 2009
CANCER experts are examining a new approach to treating ovarian cancer that reduces serious side-effects, including damage to the bowel.
The new treatment could be particularly beneficial for women with advanced ovarian cancer.
Because of the non-specific nature of symptoms, most patients are diagnosed at a late stage of the disease.
Preliminary results from clinical trials involving over 1,000 patients across Europe and New Zealand were presented at the British Gynaecological Cancer Society conference in Dublin Castle yesterday.
Professor Sean Kehoe, consultant gynaecologist at the John Radcliffe Hospital in Oxford, said a key result was that the quality of life in women with advanced ovarian cancer could be improved by giving chemo- therapy first and delaying surgery.
One trial involving 750 patients examined the benefits of offering three sessions of chemotherapy before surgery and then three sessions after. Another trial looking at the new treatment option is ongoing.
Currently, the surgical removal of the tumour is usually followed by six cycles of chemotherapy but this approach is now being examined. Dr Kehoe said they were confident clinical practice would change when the two trials were looked at together.
Around 280 new cases of ovarian cancer are diagnosed every year and the Irish Cancer Society believes that the best defence for any woman against the disease is to know their bodies, their family medical history and tell their doctor.
Symptoms include pelvic or abdominal discomfort, enlarged abdomen, unexplained weight gain or loss, fatigue, difficulty breathing, changes in bladder or bowel habits, unusual vaginal bleeding and pain during intercourse.
- Anyone concerned about gynaecological cancers or any cancer can contact the National Cancer Helpline Freefone 1800 200 700 or visit cancer.ie.
© Examiner Publications (Cork) Limited, City Quarter, Lapps Quay, Cork. Registered in Ireland: 73385.
